Skip to Content

M LP2 (Lansoprazole Delayed-Release (Orally Disintegrating) 30 mg)

Pill with imprint M LP2 is Yellow, Round and has been identified as Lansoprazole Delayed-Release (Orally Disintegrating) 30 mg. It is supplied by Mylan Pharmaceuticals Inc..

Lansoprazole is used in the treatment of barrett's esophagus; duodenal ulcer; duodenal ulcer prophylaxis; gerd; erosive esophagitis and belongs to the drug class proton pump inhibitors. There is no proven risk in humans during pregnancy. Lansoprazole 30 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for M LP2

Lansoprazole Delayed-Release (Orally Disintegrating)

Imprint
M LP2
Strength
30 mg
Color
Yellow
Shape
Round
Availability
Rx and/or OTC
Drug Class
Proton pump inhibitors
Pregnancy Category
B - No proven risk in humans
CSA Schedule
Not a controlled drug
Labeler / Supplier
Mylan Pharmaceuticals Inc.
National Drug Code (NDC)
00378-6982

Get help with Imprint Code FAQs.

Related Images for "M LP2"

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.